Tata India Pharma & Healthcare Fund-Direct Plan-Growth

As on 06 Jun 2025

logo

Tata India Pharma & Healthcare Fund-Direct Plan-Growth

Equity

NAV

34.31

CAGR (3 Years)

25.52%

AUM (Cr)

1,222.72

Risk

Very High Risk

About Tata India Pharma & Healthcare Fund-Direct Plan-Growth

To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.

Breakdown of this Fund

logo
Chemicals
0.58%
logo
Debt Others
10.79%
logo
Fertilizers
2.09%
logo
Healthcare
52.62%
logo
Insurance
1.61%
logo
IT - Software
1.04%
logo
Miscellaneous
1.54%
logo
Pharmaceuticals
99.04%
logo
Retail
1.54%

Market Capitalization

Get your FAQs right

What kind of returns does Tata India Pharma & Healthcare Fund-Direct Plan-Growth provide?

plus

How much expense ratio is charged by Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the AUM of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the PE and PB ratio of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

What is the exit load of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?

plus

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions